Going anti-anti open access

The Association of American Publishers' campaign against open access has angered one member of an AAP division so much that he has resigned, according to The Chronicle of Higher Education. James D. Jordan, president and director of Columbia University Press, linkurl:told;http://chronicle.com/news/article/3009/university-press-leader-quit-publishers-panel-over-anti-open-access-campaign The Chronicle yesterday that he had resigned from the Executive Council of the AAP's Professional and S

Written byAlison McCook
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
The Association of American Publishers' campaign against open access has angered one member of an AAP division so much that he has resigned, according to The Chronicle of Higher Education. James D. Jordan, president and director of Columbia University Press, linkurl:told;http://chronicle.com/news/article/3009/university-press-leader-quit-publishers-panel-over-anti-open-access-campaign The Chronicle yesterday that he had resigned from the Executive Council of the AAP's Professional and Scholarly Publishing division last month. In an linkurl:August release;http://www.publishers.org/main/PressCenter/PRISMLaunch.htm from the AAP, the purpose of the anti-open access campaign (Partnership for Research Integrity in Science and Medicine, or Prism) is to protect the integrity of scientific publishing from the interference of the Federal government. According to the release, open access "would jeopardize the financial viability of the journals that conduct peer review, placing the entire scholarly communication process at risk." "I resigned from the Executive Council ... because I had vocally opposed the launch of the linkurl:Prism Web site;http://www.prismcoalition.org/about.htm and did not subscribe to arguments supporting it and opposing the NIH's linkurl:public-access proposals;http://www.the-scientist.com/news/display/53366/," Jordan told The Chronicle in an Email. Stephen Bourne, chief executive officer of Cambridge University Press, also criticized Prism in an Email message to The Chronicle. "Prism's message is oversimplistic and ill-judged, with the unwelcome consequence of creating tension between the publishing community and the proponents of open access."
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies